Company: VEEV
Filing Date: 2025-05-13
Form Type: DEFA14A
Source: 0001393052-25-000031
Chunk: 1

Company: VEEVA SYSTEMS INC
Filing Date: 2025-05-13
Form: DEFA14A
Chunk 1
---
ri serves on the board of Compugen Ltd., also a clinical stage biotechnology company.

The purpose of this supplemental disclosure is to provide additional information about Mr. Sekhri’s board commitment at Compugen. On May 13, 2025, Compugen announced that Mr. Sekhri will step down from its board of directors in September 2025.

We recognize that the proxy voting guidelines of a limited number of our investors would currently consider Mr. Sekhri to be overboarded given his public company board commitments in addition to his role as a sitting CEO. As a result of Compugen’s announcement, we believe Mr. Sekhri should no longer be considered overboarded under the voting guidelines of such investors. In addition to the disclosure we have already made about Mr. Sekhri’s role on and contributions to our Board, we believe this change should address any remaining concern about his public company board commitments.

We believe that Mr. Sekhri has been, and will continue to be, an effective and engaged director who provides important perspective and immense value to our Board, in particular due to his expertise and experience in the life sciences industry.

Our Board strongly encourages you to vote FOR Mr. Sekhri on Proposal One.

#### FOR THESE REASONS, WE URGE OUR SHAREHOLDERS

#### TO VOTE “FOR” ALL DIRECTOR NOMINEES.